Program details
-
Epidemiology and genetics 1
Caring for the future in GDM: pathways, precision, and prevention
Chair(s): Hak Chul Jang, Mi Hae Seo
Thursday 10 October, 13:40~15:10
Room 3
-
This session offers a comprehensive exploration of Gestational Diabetes Mellitus (GDM) through diverse and interconnected topics. It begins with an examination of the heterogeneity and precision medicine of GDM, followed by insights into the link between metabolic dysfunction-associated fatty liver disease and cardiovascular disease in GDM patients. The session also highlights novel insights in diagnostic and treatment strategies for early gestational diabetes and emphasizes the importance of preventing the progression to type 2 diabetes postpartum.
-
-
S8-1
Marie-France HivertHarvard University, USA
-
Heterogeneity of gestational diabetes: paving the path for precision medicine
-
S8-2
Seung Mi LeeSeoul National University, Korea
-
MAFLD, connecting GDM and cardiovascular disease
-
S8-3
Arianne SweetingUniversity of Sydney, Australia
-
Diagnosis and treatment of early gestational diabetes
-
S8-4
Joon Ho MoonSeoul National University, Korea
-
Prevention of type 2 diabetes after GDM pregnancy
-
Epidemiology and genetics 2
Innovative data analysis and large-scale biobanks: transforming diabetes and metabolic disease research
Chair(s): Hyeong-Kyu Park, Sang Youl Rhee
Thursday 10 October, 17:00~18:30
Room 3
-
With advancements in large-scale biobank datasets and analysis technologies, studies using innovative data analysis are being published. In this session, we will discuss research utilizing largescale biobanks and new analysis technologies in diabetes and metabolic diseases. We will introduce an in-silico score for coronary artery disease that uses machine learning to identify cardiometabolic disease markers from biobank data. We will also examine how precision nutrition is transforming diabetes management and treatment. Additionally, we will explore type 2 diabetes microbiome research findings from shotgun metagenomic analysis. Finally, we will present new insights into diabetes prevention and management from omics research conducted in the Korean diabetes prevention study.
-
-
S11-1
Ron DoIcahn School of Medicine at Mount Sinai, USA
-
Machine learning-based prediction of coronary artery disease risk
-
S11-2
Jordi MerinoUniversity of Copenhagen, Denmark
-
Precision nutrition in diabetes
-
S11-3
Sunjae LeeGIST, Korea
-
Risk stratifications of patients with T2D by integrative multi-omics approaches
-
S11-4
Min-Jeong ShinKorea University, Korea
-
Epigenetics in the management of cardiometabolic traits: lessons from the KDPS multi-omics study
-
Epidemiology and genetics 3 - KDA–KNIH–KGS joint session (K)
Current status and challenges in elderly diabetes
Chair(s): Kang Seo Park, Won-Ho Kim
Friday 11 October, 14:20~15:50
Room 3
-
Advancements in large-scale biobank datasets and analysis technologies are driving the publication of innovative research. In this session, we will discuss studies leveraging these resources in diabetes and metabolic diseases. We will introduce an in-silico score for coronary artery disease that employs machine learning to identify cardiometabolic disease markers from biobank data. We will also explore how precision nutrition is revolutionizing diabetes management and treatment. Additionally, we will review findings from type 2 diabetes microbiome research using shotgun metagenomic analysis. Finally, we will present new insights into diabetes prevention and management from the Korean Diabetes Prevention Study's omics research.
-
-
S17-1
Seok-Jun YoonKorea University, Korea
-
Quantifying the disease burden of elderly diabetes
-
S17-2
Young Jin KimKorea National Institute of Health, Korea
-
Longitudinal study of accelerated aging and its relationship with type 2 diabetes
-
S17-3
Kwang-il KimSeoul National University, Korea
-
Advancing geriatric care in elderly diabetes: insights from recent studies and research
-
S17-4
Sung Wan ChunSoonchunhyang University, Korea
-
Research advances in metabolic regulation in elderly diabetes
- Panel discussion
-
-
S17-Panel 1
Joo Hyun LimKorea National Institute of Health, Korea
-
S17-Panel 2
Eunok BahngKorea Disease Control and Prevention Agency, Korea
-
S17-Panel 3
Kang Seo ParkEulji University, Korea
-
S17-Panel 4
Jae-Seung YunThe Catholic University of Korea, Korea